Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations

Tirtha Chakraborty, Chief Scientific Officer of Vor Biopharma Inc., sold 985 shares of common stock on May 1, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On May 1, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 985 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations related to the settlement of restricted stock units.
• The shares were sold at a price of $1.77 per share.
• Following the transaction, Chakraborty directly owns 180,108 shares of Vor Biopharma Inc.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it involves a small number of shares sold by an executive to cover tax obligations.

Key Dates